Pending FDA Approval of Bemotrizinol: A Potential Turning Point for U.S. Sunscreen Formulation

Journal:
Journal of the American Academy of Dermatology
Published:
DOI:
10.1016/j.jaad.2026.04.1970
Affiliations:
3
Authors:
3
Go to article
Institutions Authors Share
Hoag Memorial Hospital Presbyterian, United States of America (USA)
1.000000
 0.33
Sun Protection Facilitator (SPF), Switzerland
1.000000
 0.33
Henry Ford Health System (HFHS), United States of America (USA)
1.000000
 0.33
Interested in Ecology?